AARD
Aardvark Therapeutics, Inc. Common Stock
NASDAQ: AARD · HEALTHCARE · BIOTECHNOLOGY
$5.21
-6.80% today
Updated 2026-04-29
Market cap
$113.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.93
Dividend yield
—
52W range
$3 – $18
Volume
0.3M
Aardvark Therapeutics, Inc. Common Stock (AARD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-64.40%
ROA
-40.30%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-13.56M | — | — | — |
| 2023 | $0.00 | $-7.21M | — | — | — |
| 2024 | $0.00 | $-20.59M | — | — | — |
| 2025 | $0.00 | $-57.59M | — | — | — |